Clinical Trials Browser

Phase NA × INDUSTRY × Lymphoma, T-Cell × Clear all

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT04928105 2022-05-31

Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma

Phase NA Unknown

100 enrolled

Lymphoid

Lymphoma, T-Cell

Clinical Trials

MargheRITA

Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma